Fmr LLC Sells 2,380,516 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Fmr LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 7.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 30,120,629 shares of the healthcare conglomerate’s stock after selling 2,380,516 shares during the quarter. UnitedHealth Group comprises about 0.9% of Fmr LLC’s holdings, making the stock its 14th largest position. Fmr LLC’s holdings in UnitedHealth Group were worth $15,236,821,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the stock. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $25,000. Hurley Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $28,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $30,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group in the fourth quarter valued at $30,000. Finally, Promus Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH opened at $524.94 on Friday. The firm has a market cap of $480.17 billion, a PE ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a 50-day moving average price of $509.24 and a 200-day moving average price of $542.12.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the firm earned $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analysts Set New Price Targets

Several equities analysts recently commented on UNH shares. KeyCorp reaffirmed an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. Finally, Truist Financial lowered their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.